AR022819A1 - Composiciones farmaceuticas para la administracion oral que comprenden un principio activo de la familia de las benzamidas, asi como por lo menos unpromotor de absorcion - Google Patents

Composiciones farmaceuticas para la administracion oral que comprenden un principio activo de la familia de las benzamidas, asi como por lo menos unpromotor de absorcion

Info

Publication number
AR022819A1
AR022819A1 ARP000100941A ARP000100941A AR022819A1 AR 022819 A1 AR022819 A1 AR 022819A1 AR P000100941 A ARP000100941 A AR P000100941A AR P000100941 A ARP000100941 A AR P000100941A AR 022819 A1 AR022819 A1 AR 022819A1
Authority
AR
Argentina
Prior art keywords
well
pharmaceutical compositions
family
absorption
benzamid
Prior art date
Application number
ARP000100941A
Other languages
English (en)
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of AR022819A1 publication Critical patent/AR022819A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Composiciones farmacéuticas que comprenden un principio activo de la familia de las benzamidas, así como por lo menos un promotor de absorcion que puedeser un inhibidor de la P-glicoproteína.
ARP000100941A 1999-03-04 2000-03-03 Composiciones farmaceuticas para la administracion oral que comprenden un principio activo de la familia de las benzamidas, asi como por lo menos unpromotor de absorcion AR022819A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9902680A FR2790388B1 (fr) 1999-03-04 1999-03-04 Compositions pharmaceutiques comprenant un benzamide et au moins un promoteur d'absorption

Publications (1)

Publication Number Publication Date
AR022819A1 true AR022819A1 (es) 2002-09-04

Family

ID=9542809

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000100941A AR022819A1 (es) 1999-03-04 2000-03-03 Composiciones farmaceuticas para la administracion oral que comprenden un principio activo de la familia de las benzamidas, asi como por lo menos unpromotor de absorcion

Country Status (9)

Country Link
JP (1) JP2002538094A (es)
AR (1) AR022819A1 (es)
AU (1) AU2922800A (es)
CA (1) CA2362480A1 (es)
CO (1) CO5440229A1 (es)
FR (1) FR2790388B1 (es)
PE (1) PE20001554A1 (es)
UY (1) UY26050A1 (es)
WO (1) WO2000051563A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2857263B1 (fr) * 2003-07-09 2005-09-09 Sanofi Synthelabo Nouvelle composition pharmaceutique solide comprenant de l'amisulpride
AR071375A1 (es) * 2008-04-22 2010-06-16 Solvay Pharm Gmbh Formulaciones para ingredientes farmaceuticos activos de permeabilidad deficiente, proceso de preparacion y producto
CN101507432B (zh) * 2009-04-02 2012-12-19 河北省林业科学研究院 香芹酚微乳剂及其生产工艺

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8605515D0 (sv) * 1986-12-22 1986-12-22 Astra Laekemedel Ab A liquid dosage form for oral administration of a pharmaceutically active substance
EP0303445A1 (en) * 1987-08-13 1989-02-15 Walton S.A. Clebopride transdermal patch
JPH01236980A (ja) * 1988-03-14 1989-09-21 Iseki & Co Ltd 小米選別装置付き貯留タンク
FR2753376B1 (fr) * 1996-09-18 1998-10-16 Synthelabo Compositions pharmaceutiques comprenant de l'amisulpride et leurs applications therapeutiques
FR2762213B1 (fr) * 1997-04-18 1999-05-14 Synthelabo Composition pharmaceutique a retention gastrique

Also Published As

Publication number Publication date
UY26050A1 (es) 2000-09-29
CO5440229A1 (es) 2004-09-30
WO2000051563A1 (fr) 2000-09-08
JP2002538094A (ja) 2002-11-12
FR2790388B1 (fr) 2001-04-13
FR2790388A1 (fr) 2000-09-08
CA2362480A1 (fr) 2000-09-08
PE20001554A1 (es) 2001-03-18
AU2922800A (en) 2000-09-21

Similar Documents

Publication Publication Date Title
ES2156603T3 (es) Medicamentos a base de una mezcla sinergetica de metronidazol y de clindamicina.
PT1300398E (pt) Processos e composicoes para terapias do cancro, utilizando genes que codificam o interferao-beta
ECSP055582A (es) Derivados de benzotiazol que tienen actividad agonista de beta-2-adrenorreceptor
BRPI0415121A (pt) material particulado, forma de dosagem sólida, método para fabricar a mesma, e, uso de um material particulado ou de uma forma de dosagem sólida
GT199900203A (es) Composiciones de celecoxib.
AR019690A1 (es) Formulacion farmaceutica para aerosoles con dos o mas sustancias activas
AR021981A1 (es) Composicion farmaceutica para una administracion por via oral destinada a evitar la desviacion de uso en detrimento de un tercero
BR0306870A (pt) Composição farmacêutica oral, e, método para preparar a mesma
BR0207726A (pt) Sais farmacêuticos
HN2002000247A (es) Derivados de sulfonamida
BR0112376B1 (pt) combinaÇço sinÉrgica de compostos ativos herbicidas, bem como processos para combater plantas indesejadas e preparar uma composiÇço herbicida.
ES2159591T3 (es) Composicion de liberacion controlada.
BRPI0417072A (pt) agente preventivo para a vasculite
PT750618E (pt) Derivados de oxazolidinona e composicoes farmaceuticas que os contem
MX9202407A (es) Composicion farmaceutica que contiene un compuesto de alilamina como el agente activo y proceso para su preparacion.
CU23346A3 (es) Herbicidas a base de amicarbazona
HRP20050510A2 (en) Microbicide substances
MXPA06011467A (es) Combinacion de sustancias activas que comprenden un carbinol combinado con al menos un farmaco antiinflamatorio no esteroideo (nsaid).
MX2007008227A (es) Prevencion de trastornos tromboticos con compuestos de vitamina d activa o mimeticos de los mismos.
CY1108676T1 (el) Οφθαλμικο εναιωρημα περιλαμβανον ενα οφθαλμικο φαρμακο, μια πολοξαμινη και εναν παραγοντα ρυθμισεως της τονικοτητας τυπου γλυκολης, χρηση της εν λογω συνθεσεως για την παραγωγη ενος φαρμακου για την αγωγη οφθαλμικων διαταραχων
ECSP078057A (es) Formulaciones de estrógenos conjugados y bazedoxifeno
AR110174A2 (es) Agentes endoparasiticidas y procedimiento de preparación
NO20064808L (no) Orale matrixformuleringer med licarbazepin
PT1121127E (pt) Composicoes farmaceuticas orais contendo buprenorfina
PA8532001A1 (es) Bifenilcarboxamidas utiles como agentes reductores de lipidos